Short- and long-term mortality in males and females with fragility hip fracture in Norway. A population-based study

Figures & data

Table 1 Outcome, mortality rates, and relative risk of fragility hip fracture patients compared to controls at the first and fifth years after hip fracture in southern Norway in 2004–2005

	Age at the time of injury	Patients, n	Controls, n	Number of deceased				Mortality rate per 100 patient-years (95% CI)		Relative risk (95% CI)
				1st year		5th year
				Patients, n	Controls, n	Patients, n	Controls, n	1 st year	5th year	1 st year	5th year
Males	50–80 years	126	351	19	10	58	45	15.0(8.7–21.2)	46.0* (37.3–54.7)	5.2(2.5–11.0)	3.5 (2.5–5.0)
	80+ years	141	450	63	38	129	163	44.6* (36.4–52.8)	91.4* (86.7–96.0)	3.9 (2.7–5.7)	2.5 (2.2–2.8)
	All	267	801	82	48	187	208	30.7(26.8–38.1)	70.0 (64.5–75.5)	4.1 (2.9–5.8)	2.0(1.7–2.3)
Females	50–80 years	263	723	23	14	92	65	8.7(5.3–12.1)	34.9* (29.1–40.6)	4.5(2.2–8.1)	3.1 (2.3–4.2)
	80+ years	412	1302	96	96	277	431	23.3* (19.2–27.3)	67.2* (62.6–71.7)	2.7(2.1–3.6)	2.0(1.8–2.2)
	All	675	2025	119	110	369	496	19.1 (16.1–22.0)	54.6 (50.8–58.3)	2.9 (2.3–3.7)	1.8(1.6–2.0)
All	50–80 years	389	1074	42	24	150	110	10.7(7.6–13.7)	38.5 (33.6–43.3)	4.8 (2.9–7.8)	3.7 (3.0–4.6)
	80+ years	553	1752	159	134	406	594	28.7 (24.9–32.4)	73.4 (69.7–77.0)	3.7 (3.0–4.6)	2.1 (1.9–2.3)
	All	942	2826	201	158	556	704	21.3(18.7–23.9)	59.0(55.8–62.1)	3.8(3.1–4.6)	2.3(2.1–2.5)

Note:

* Statistically significant difference between the sexes (P < 0.05).

Abbreviation: CI, confidence interval.

Figure 1 Kaplan–Meier survival analysis in males and females with a fragility hip fracture in 2004–2005 in southern Norway compared to matched controls.

Figure 2 Kaplan–Meier survival analyses in males and females with a fragility hip fracture in 2004–2005 in southern Norway.

Notes: (A) Age group 50–80 years; (B) age group 80+ years.

Figure 3 Kaplan–Meier survival analysis in patients with a fragility hip fracture in 2004–2005 in southern Norway (indicated with Yes) compared to matched controls (indicated with No).

Table 2 Mortality OR estimates in relation to time since fracture in males and females compared to controls

Time after hip fracture	OR (95% CI)
	Males	Females	All
0–3 months	10.5 (5.7–19.5)	6.5 (4.2–10.0)	8.6 (6.0–12.2)
3–6 months	2.5 (1.2–5.2)	2.3 (1.3–4.0)	2.7 (1.7–4.2)
6–12 months	3.1 (1.7–5.7)	1.8 (1.2–2.8)	2.2 (1.5–3.2)
1–2 years	2.5 (1.6–3.7)	2.0 (1.5–2.7)	2.3 (1.8–2.9)
2–3 years	3.2 (2.1–5.0)	2.4 (1.8–3.2)	2.9 (2.3–3.7)
3–4 years	2.3 (1.3–3.8)	2.5 (1.8–3.5)	2.6 (2.0–3.4)
4–5 years	2.4 (1.2–4.8)	2.1 (1.5–2.9)	2.3 (1.7–3.1)

Abbreviations: CI, confidence interval; OR, odds ratio.